Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2018

Allosteric coupling of CARMIL and V-1 binding to capping protein
revealed by hydrogen-deuterium exchange
Britney Johnson
Washington University School of Medicine in St. Louis

Patrick McConnell
Washington University School of Medicine in St. Louis

Alex G. Kozlov
Washington University School of Medicine in St. Louis

Marlene Mekel
Washington University School of Medicine in St. Louis

Timothy M. Lohman
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Johnson, Britney; McConnell, Patrick; Kozlov, Alex G.; Mekel, Marlene; Lohman, Timothy M.; Gross,
Michael L.; Amarasinghe, Gaya K.; and Cooper, John A., ,"Allosteric coupling of CARMIL and V-1 binding to
capping protein revealed by hydrogen-deuterium exchange." Cell Reports. 23,9. 2795-2804. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6888

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Britney Johnson, Patrick McConnell, Alex G. Kozlov, Marlene Mekel, Timothy M. Lohman, Michael L.
Gross, Gaya K. Amarasinghe, and John A. Cooper

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/6888

Article

Allosteric Coupling of CARMIL and V-1 Binding to
Capping Protein Revealed by Hydrogen-Deuterium
Exchange
Graphical Abstract

Authors
Britney Johnson, Patrick McConnell,
Alex G. Kozlov, ..., Michael L. Gross,
Gaya K. Amarasinghe, John A. Cooper

Correspondence
gamarasinghe@wustl.edu (G.K.A.),
jcooper11@gmail.com (J.A.C.)

In Brief
Using hydrogen deuterium exchange
mass spectrometry, Johnson et al. show
how a key actin regulator, capping
protein (CP), is allosterically controlled by
two inhibitory proteins, CARMIL and V-1.

Highlights
d

Actin assembly is tightly controlled and capping protein (CP)
plays an important role

d

CP binding to actin filaments is regulated by CARMIL and V-1

d

HDX-MS is used to show that CARMIL and V-1 binding sites
are allosterically coupled

d

The results provide a framework to study CP regulators by
HDX-MS methods

Johnson et al., 2018, Cell Reports 23, 2795–2804
May 29, 2018 ª 2018 The Author(s).
https://doi.org/10.1016/j.celrep.2018.04.096

Cell Reports

Article
Allosteric Coupling of CARMIL and V-1
Binding to Capping Protein Revealed
by Hydrogen-Deuterium Exchange
Britney Johnson,1 Patrick McConnell,2 Alex G. Kozlov,2 Marlene Mekel,2 Timothy M. Lohman,2 Michael L. Gross,3
Gaya K. Amarasinghe,1,4,* and John A. Cooper2,*
1Department

of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA
of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA
3Department of Chemistry, Box 1134, Washington University, One Brookings Drive, St. Louis, MO 63130, USA
4Lead Contact
*Correspondence: gamarasinghe@wustl.edu (G.K.A.), jcooper11@gmail.com (J.A.C.)
https://doi.org/10.1016/j.celrep.2018.04.096
2Department

SUMMARY

Actin assembly is important for cell motility. The ability of actin subunits to join or leave filaments via the
barbed end is critical to actin dynamics. Capping
protein (CP) binds to barbed ends to prevent subunit
gain and loss and is regulated by proteins that
include V-1 and CARMIL. V-1 inhibits CP by sterically
blocking one binding site for actin. CARMILs bind at
a distal site and decrease the affinity of CP for actin,
suggested to be caused by conformational changes.
We used hydrogen-deuterium exchange with mass
spectrometry (HDX-MS) to probe changes in structural dynamics induced by V-1 and CARMIL binding
to CP. V-1 and CARMIL induce changes in both proteins’ binding sites on the surface of CP, along with a
set of internal residues. Both also affect the conformation of CP’s bb subunit ‘‘tentacle,’’ a second distal
actin-binding site. Concerted regulation of actin assembly by CP occurs through allosteric couplings
between CP modulator and actin binding sites.
INTRODUCTION
Dynamic assembly and disassembly of the actin cytoskeleton
are key determinants of cell shape and movement (Pollard and
Cooper, 2009). Actin assembles into filaments with barbed
(plus) ends and pointed (minus) ends, with the barbed ends
thermodynamically and kinetically favored for polymerization
(Pollard and Cooper, 2009). In cells, barbed ends are often
oriented toward a membrane, and polymerization from those
filament ends can drive movement of that membrane and associated structures, such as organelles and pathogens (Carlier
et al., 2015). Cells regulate barbed-end polymerization via
different proteins that bind to the barbed end and inhibit or promote the gain or loss of actin subunits at the barbed end.
The a/b heterodimeric actin capping protein (CP) is one such
regulator (Cooper and Sept, 2008). CP is widely distributed
across eukaryotic organisms and cell types. CP binds tightly to

barbed ends and prevents gain and loss of subunits. In cells,
the concentration of CP (mM) and the affinity of CP for barbed
ends (nM) would be sufficient to cap all barbed ends. To initiate
actin assembly and movement, cells activate nucleators of actin
polymerization, notably Arp2/3 complex and formins, near membranes (Carlier et al., 2015; Skau and Waterman, 2015). These
nucleators create free barbed ends, which polymerize and
push on the membrane until the ends become capped. Arp2/3
complex creates branched networks of actin filaments, and
capping barbed ends is necessary for actin polymerization and
actin-driven motility to exist and proceed continuously at steady
state (Loisel et al., 1999). Formins create filaments that are not
branched; a formin dimer remains with the growing barbed end
and protects it from being capped by CP (Goode and Eck, 2007).
The a and b subunits of CP are extensively intertwined into a
conformation that melts in a single irreversible transition (Yamashita et al., 2003; Sizonenko et al., 1996). X-ray crystal structural
models show that CP has a pseudo 2-fold rotational axis of symmetry, and the two subunits have similar secondary structural
elements and tertiary folds (Yamashita et al., 2003) (Figure 1).
Overall, the CP structure has the shape of a mushroom. The stalk
of the mushroom, known as the N-stalk, is composed of six a helices from the N termini, three from the a subunit (H1a, H2a, and
H3a) and three from the b subunit (H1b, H2b, and H3b) (Figure 1).
Above the stalk sits a central b sheet with 10 strands of alternating polarity, five from each subunit. Above the b sheet, a single long a helix from each subunit crosses the surface (H5a and
H5b, i.e., ‘‘antiparallel helices 5’’) (Yamashita et al., 2003), terminating with a shorter C-terminal region often called a ‘‘tentacle’’
(H6a and H6b).
The top surface of the mushroom is one of two major binding
sites for the barbed end of the actin filament (Wear et al., 2003;
Kim et al., 2010; Narita et al., 2006) (Figure 1). This region includes hydrophilic and charged residues, located on the C-terminal tentacle of the a subunit and on the exposed surfaces of
the a helices of the a and b subunits that cross the mushroom
top. The second actin-binding site consists of the hydrophobic
side of the amphipathic helix that constitutes the C-terminal
tentacle of the CP b subunit (Wear et al., 2003; Kim et al.,
2010; Narita et al., 2006). The hydrophobic side of this amphipathic helix binds to a hydrophobic groove on the surface of

Cell Reports 23, 2795–2804, May 29, 2018 ª 2018 The Author(s). 2795
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Figure 1. Diagrammatic Structure of CP Heterodimer
Two views of ribbon representations of two CP
crystal structures from PDB 3AAE (Takeda et al.,
2010). CP a and b subunits are shown in gray and
pink, respectively. The N-stalk (H1, H2, H3), central
b sheet (S5-S9), a- and b-globules, antiparallel helices (H5), and a- and b-tentacle (H6) regions of CP
are labeled, following the nomenclature of Yamashita et al. (2003).

actin, which serves as the binding site for WH2 domains of
several actin regulatory proteins (Dominguez, 2016). Structural
and biochemical studies led Narita and colleagues to propose
a two-step model (Narita et al., 2006) for CP binding to the
barbed end. The first step is an electrostatic interaction between
the first site described above with the two end protomers of the
barbed end. The second step is the hydrophobic interaction of
the second site described above with one end protomer. The first
step is proposed to primarily influence the association rate, while
the second step is proposed to primarily influence the dissociation rate (Narita et al., 2006).
CP regulation is critical for proper cytoskeletal function, and
the actin-binding activity of CP can be regulated by other proteins, which function in two distinct modes (Takeda et al.,
2010). In the first mode, a protein known as V-1 or myotrophin
can bind electrostatically to the polar actin-binding site on the
top surface of the CP mushroom, competing directly for binding
to actin (Jung et al., 2016; Zwolak et al., 2010a; Bhattacharya
et al., 2006; Takeda et al., 2010). This steric blocking mechanism
is derived from biochemical studies of actin polymerization and
structural studies of complexes of V-1 with CP.
In the second mode, a diverse set of otherwise unrelated proteins with CP-interacting (CPI) motifs, including CP ARP2/3
myosin I linker (CARMIL), CD2-associated protein (CD2AP),
casein kinase 2 interacting protein (CKIP-1), and the Fam21 subunit of WASH- and capping-protein-associated protein (Fam21/
WASHCAP), bind to the undersurface of the mushroom, around
the N-stalk (Hernandez-Valladares et al., 2010; Edwards et al.,
2014). This binding appears to induce a conformational change
that allosterically affects actin binding, based on biochemical
studies of actin polymerization and structural studies of complexes of CPI motifs with CP (Kim et al., 2012; Takeda et al.,
2010; Zwolak et al., 2010a; Hernandez-Valladares et al., 2010).
The allosteric nature of the interaction imparts CPI motifs with
the ability to promote the dissociation of CP from barbed ends
of actin filaments that are capped by CP, i.e., ‘‘uncap’’ a barbed
end (Yang et al., 2005; Fujiwara et al., 2010). The complex of CP
with a CPI motif does retain a lower level of capping activity, and
this level appears to be physiologically relevant in cells (Edwards
et al., 2015).
The steric blocking mechanism for V-1 implies that the V-1/CP
complex, which exists in cells (Jung et al., 2016), is not able to
2796 Cell Reports 23, 2795–2804, May 29, 2018

cap barbed ends. The allosteric effect of
the CPI motif weakens the binding of CP
for V-1, in addition to affecting actin binding (Fujiwara et al., 2010). The converse,
how the binding of V-1 to CP affects the affinity of a CPI motif
for CP, is not known. Current data point to coupling between
CPI molecules; however, the mechanistic basis of the coupling
remains to be established.
This combination of actions led Fujiwara and colleagues to
propose a model for actin polymerization in cells in which CPImotif proteins function locally to enhance the activity of CP by
promoting the dissociation of V-1, which diffuses rapidly to function as a global inhibitor (Fujiwara et al., 2014). Support for this
model comes from the observation that the phenotype of certain
point mutants of CP, which are unable to bind a CPI motif, resembles the loss of CP (Edwards et al., 2015).
In this study, we sought to test the molecular basis for this
model by examining how the structural dynamics of CP are
affected by the binding of V-1 and CARMIL. We used
hydrogen-deuterium exchange with mass spectrometry (HDXMS) to interrogate the conformational dynamics and solvent
accessibility of the backbone and side chains of CP, free and
in complex with V-1 and fragments of CARMIL that include CPI
motifs. Our results indicate that the binding of V-1 and CARMIL
result in structural dynamic perturbations, involving a common
set of residues, which reveals linkage between the conformations of the two binding sites and known actin-binding sites
and provides insight into the molecular mechanism of CP
regulation.
RESULTS
CP a-Tentacle, b-Tentacle, and N-Stalk Are Dynamic or
Solvent Exposed
Rates of amide hydrogen exchange with solvent D2O are determined in part by local fluctuations in protein structure and
thereby report on protein conformational dynamics. To determine CP conformational fluctuations, we employed HDX-MS
(Chalmers et al., 2011; Pascal et al., 2012) to derive the first
peptide-level analysis of solvent accessibility for CP. CP was
deuterium labeled at exchangeable protons (amide protons) for
10, 30, 60, 120, 900, 3,600, and 14,400 s (i.e., up to 4 hr) and
digested online with pepsin. In a preliminary experiment, the
peptic peptides were identified by high resolving power, accurate-mass analysis to cover 99% of the sequence. Upon incubation in D2O, HDX extent was measured at each time point by

Figure 2. HDX-MS Analysis of Solvent Accessibility for CP
Cartoon representation of a CP crystal structure from PDB 3AAE (Takeda et al., 2010). The percentage of deuterium incorporation for representative peptides is
mapped for 6 incubation times (10 s, 1 min, 2 min, 15 min, 1 hr, and 4 hr). Relative deuterium uptake for representative peptides is displayed as a color gradient
(see scale at bottom) and highlighted in the cartoon representation. Data shown are representative of two independent experiments with error bars (SEM). See
also Figures S1–S4 and Table S1.

subtracting the centroid of the isotopic distribution of the nondeuterated peptide from that of the deuterated peptide. The percentage of deuterium uptake, relative to the maximum measured
deuterium incorporation based on the peptide mass for each
peptide, was mapped onto a crystal structure of CP (PDB:
3AAE [Takeda et al., 2010]). The results are displayed in Figures 2
and S1 with a color scheme superimposed on the structure. Corresponding kinetic curves for individual peptides are shown in
Figures S2 and S3.
Monitoring the rate of deuterium incorporation revealed solvent-accessible regions of CP. The C-terminal CP a- and b-tentacles (Figure S1A) exchanged rapidly, with >50% deuterium
uptake at the shortest incubation time (10 s). CP a subunit C-terminal peptides, corresponding to residues 247–255, 256–267,
266–276, and 278–286, reached maximum deuterium uptake
within 15 min. In contrast, CP b subunit C-terminal peptides corresponding to residues 249–264 and 265–272 exchanged more
quickly, reaching maximum deuterium uptake within 10 s. These
results indicate that, while both CP a- and b-tentacles are likely
solvent exposed, the b-tentacle is relatively more accessible to

the solvent than is the a-tentacle. The depicted a-helical character of the b-tentacle may not be applicable to the solution
structure. The HDX of the b-tentacle is consistent with an intrinsically disordered region, and nuclear magnetic resonance
(NMR) studies of CP in solution support this view (Zwolak
et al., 2010a). In crystal structures in which the b-tentacle is
resolved, two a-helical conformations have been observed (Figure S4). In one conformation, the a helix extends out from the
body of the mushroom; in the other, it is oriented closer toward
the surface of the a subunit’s globule domain (PDB 3AAE,
1IZN, 2KZ7, 2KXP) (Takeda et al., 2010; Yamashita et al.,
2003; Zwolak et al., 2010a). Structures of CP bound to the
actin-like Arp1 filament in dynactin complex, derived from cryoelectron microscopy (cryo-EM), also show the b-tentacle in an
a-helical conformation, in contact with actin (Urnavicius et al.,
2015; Urnavicius et al., 2018), and in a position consistent with
the model for CP binding to actin (Narita et al., 2006).
Other regions of CP displayed less deuterium incorporation,
compared to the C-terminal regions (Figures 2, S2, and S3).
The CP a subunit residues 5–128 and b subunit residues 1–119
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Figure 3. HDX-MS Analysis of CP, Comparing V-1/CP Complex with Free CP
(A) Cartoon representation of a co-crystal structure of V-1 (green surface) and CP (ribbon), based on PDB 3AAA (Takeda et al., 2010). Differences in deuterium
uptake induced by V-1 binding to CP are displayed as a color gradient (see scale at bottom) and highlighted in the cartoon representation of CP.
(B and C) Representative comparisons of deuterium uptake curves for free CP (black) with V-1-bound CP (pink) for CP a (B) and b (C) subunits, respectively. Data
shown are representative of two independent experiments with error bars (SEM).
See also Figures S2 and S3.

comprise the N-stalk and the globule regions, and they showed a
different pattern of deuterium uptake than C-terminal tentacles.
These regions displayed moderate deuterium uptake (<40%)
within 10 s (Figures 2, S1A, S2, and S3) and more extensive
deuterium uptake at longer times (Figures 2, S1B, S2, and S3).
The a helices of the CP N-stalk bundle (a 5–69 and b 11–70) displayed significantly slower exchange rates than did the CP C-terminal helices, likely a result of packing and local interactions
within the helix bundle. In addition, peptides of the CP central
b sheet, a 129–217 and b 119–179, showed slower exchange
than other CP regions, corroborating molecular dynamic simulations (Koike et al., 2016; Lukman et al., 2012) (Figures 2 and S1–
S3). Even at the longest HDX incubation time (14,400 s), lower
levels of deuterium uptake for peptides corresponding to the
CP central b sheet were observed; they represent low exchange
most likely due to hydrogen bonding with backbone amide
protons of adjacent strands and low solvent accessibility due
to protection by the antiparallel helices (helix 5) along the top
of the mushroom-like CP structure (Figure S1B). In contrast,
CP helices comprising the CP N-stalk, a- and b-tentacles displayed high relative HDX (>60%) at extended incubation times
(>1 hr) (Figure S1B). Together, these results indicate that peptides corresponding to the CP N-stalk and the a- and b-tentacles
2798 Cell Reports 23, 2795–2804, May 29, 2018

are significantly more accessible and flexible than other protein
regions.
Effects of V-1 Binding to CP
To characterize the structural dynamics of CP upon V-1 binding
and the interaction interface between CP and V-1, we performed
HDX-MS on the CP/V-1 complex, with a saturating concentration of V-1. Samples of unbound CP and CP/V-1 complex were
evaluated for structural perturbations upon complex formation,
as determined by differential HDX rates. These results are shown
in Figures 3, S2, and S3. In the CP/V-1 complex, the binding site
for V-1 on CP displayed protection from exchange. The CP a
subunit antiparallel helix 5 (Yamashita et al., 2003) and the
a-tentacle (peptides spanning CP residues a 239–276), were
protected >15% from deuterium uptake. This result agrees
well with the CP/V-1 interface identified in a crystal structure
(PDB 3AAA [Takeda et al., 2010]) and a solution NMR structure
(PDB 2KXP [Zwolak et al., 2010a]).
Previous studies demonstrated that the binding of CP for
V-1 is weakened by the binding of CARMIL at the distal CP
N-stalk, suggesting long-range coupling of the V-1 and
CARMIL binding sites (Fujiwara et al., 2014). To provide insight
into the nature of this coupling, we examined perturbations

Figure 4. HDX-MS Analysis of V-1, Comparing V-1/CP Complex with
Free V-1
A cartoon representation of V-1 (ribbon) bound to CP (green surface) is shown,
based on PDB 3AAA (Takeda et al., 2010). Differences in deuterium uptake
induced by CP binding are displayed as a color gradient (see scale at bottom)
and highlighted in the cartoon representation of V-1. Representative comparison of deuterium uptake curves of V-1 (black) and CP-bound V-1 (purple)
are to the right. Data shown are representative of two independent experiments with error bars (SEM). See also Figure S5.

outside the V-1 direct-binding site, looking first at the CARMILbinding site.
CARMIL contains two known binding sites for CP, in tandem.
Structural and biochemical studies identified two motifs: CPI (CP
interacting) (residues 971–1004) and CSI (CARMIL-specific interacting) (residues 1021–1035) (Hernandez-Valladares et al., 2010;
Takeda et al., 2010; Zwolak et al., 2010b). The CPI and CSI motifs correspond to segments also referred to as CAH3a and
CAH3b (Zwolak et al., 2010b). These two motifs wrap around
the CP N-stalk at sites distant from the top of the mushroom
structure, where the V-1 binding site and one actin-binding site
are located. In co-crystal structures, the CPI motif directly contacts CP N-stalk helices H2a, H1b, and H3b (Figure 1), and the
CSI motif interacts with the other side of the CP mushroom stalk,
lying opposite to the CPI motif, where it contacts CP N-stalk helices H2b and central b sheet strands S7, S8, S9, S8, and S9
(Figure 1).
Indeed, our HDX results revealed that V-1 binding to CP led to
protection (<20%) of distal CP N-stalk helices, a 5–46 (H1a and
H2a) and b 2–28 (H1b and H2b), which contain binding sites for
both the CPI motif and the CSI motif (Figures 3, S3, and S4). In
addition, V-1 binding resulted in protection of certain CP central
b sheet residues (b 131–219), those composing the b sheet
strands nearest the a/b inter-subunit interface, b 175–219 (S8b
and S9b) and a 193–206 (S8a and S9a). Unexpectedly, we found
that V-1 binding also led to moderate protection (5%–10%) of
the CP b-tentacle, the amphipathic helix for which the hydrophobic side constitutes a second actin-binding site of CP. The
b-tentacle is also distal to the direct-binding site of V-1 on CP.
In sum, these results indicate that V-1 binding to CP
affects deuterium uptake at the direct-binding site for V-1, and
that V-1 binding allosterically influences the CP a-tentacle,
b-tentacle, and N-stalk. V-1 binding increases the solvent acces-

sibility of residues of both the CPI and CSI binding sites, possibly
providing a basis for its modulation of CP binding to CARMIL,
and of the b-tentacle, which may contribute to V-1 effects on
actin binding.
Next, we employed HDX for the V-1 polypeptide binding,
comparing V-1 alone with the CP/V-1 complex (Figures 4 and
S5). We observed decreased HDX at sites of CP/V-1 complex
formation. Direct-binding V-1 residues were defined in previously solved crystal and solution NMR structures of the complex
(Takeda et al., 2010; Zwolak et al., 2010a). The residues include
the N-terminal residues, Trp8, Lys11, Asn12, Arg36, Asp44,
Gln47, His67, Ile69, Tyr77, and Glu78, which bind the CP
a-tentacle, and residues Glu5, Trp8, Ala9, Lys11, Asn12,
Asp14, Asp16, Glu17, and Tyr41, which bind central bsheet
strands of the CP bsubunit. Comparing CP/V-1 with V-1 alone,
we found substantial protection levels (>15%) for V-1 N-terminal
helices (residues 2–48 (Figures 4 and S5). Moderate protection
was also observed in V-1 helices (residues 49–75), and minimal
differential HDX was detected for other V-1 residues 76–118.
The observed protection of V-1 N-terminal residues is likely
due to decrease solvent exposure and increased H bonding
from the direct binding of CP.
Effects of CARMIL Binding to CP
In addition to the CPI motif (residues 971–1004) and the CSI motif
(residues 1021–1035), a third region of CARMIL, C-terminal to
the CSI motif, has been found to contribute to the biochemical
effect of CARMIL on CP, based on actin polymerization studies
(Hernandez-Valladares et al., 2010; Zwolak et al., 2010b). This
third region of CARMIL has been called CAH3c (Zwolak et al.,
2010b). Neither crystallography nor solution NMR studies have
provided information about the structure of this region (Hernandez-Valladares et al., 2010; Takeda et al., 2010; Zwolak et al.,
2010b), presumably due to its relative lack of order.
Because HDX reports on order and disorder in the structure of
a protein, it is particularly well suited to provide insight into the
structural dynamics and function of the different regions of
CARMIL, including the unstructured ones. We tested two fragments of CARMIL that differed by the third region. CP binding
region 71 (CBR71) is a 71-aa fragment composed of CARMIL
residues 964–1034, which includes the CPI motif and the CSI
motif; CBR71 corresponds to CAH3a/b. CBR115 is a 115-aa
fragment composed of CARMIL residues 964–1078; CBR115 includes CBR71 plus the third C-terminal region (CAH3c).
We evaluated a series of samples, including unbound CP, CP/
CARMIL CBR115, and CP/CARMIL CBR71, at saturating levels
of CARMIL, for structural perturbations upon complex formation,
as determined by differential HDX rates. CARMIL CBR115 binding caused differential HDX of CP a and b subunits (Figures 5, S6,
and S7). CP N-stalk helices (a 5–38 and b 2–70) showed the highest levels of protection, at >15%. These results are consistent
with the direct CARMIL binding site determined previously by
X-ray crystal and solution NMR structures of CARMIL-bound
CP (Hernandez-Valladares et al., 2010; Takeda et al., 2010; Zwolak et al., 2010b).
Perturbations were also observed for regions away from the
direct CARMIL binding site. CP a subunit peptides 239–246,
247–255, and 256–267 were significantly protected (>20%)
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Figure 5. HDX-MS Analysis of CP, Comparing CARMIL CBR115-Bound CP with Free CP
A cartoon representation of CARMIL CBR115-bound CP is shown, based on PDB 3LK3 (Hernandez-Valladares et al., 2010). CARMIL CBR115 is shown as green
surface, with its unresolved residues 1005–1020 between CPI and CSI motifs modeled and C-terminal residues 1034–1078 indicated as a dashed line. Differences in deuterium uptake induced by CARMIL CBR115 binding are displayed as a color gradient (see scale at bottom). Representative comparison of deuterium
uptake curves of CP (black) and CARMIL CBR115-bound CP (blue) are shown on the right. Data shown are representative of two independent experiments with
error bars (SEM). See also Figures S6 and S7.

upon CARMIL binding; these peptides contain residues involved
in V-1 binding at the top of the mushroom-like CP structure
(Figures 5, S6, and S7). In addition, CP central b sheet peptides,
b 175–179 and b 176–196, near the V-1 binding site were
protected >5% from HDX upon CARMIL binding. Unexpectedly,
the highly dynamic CP b-tentacle was also protected (>25%)
in the CARMIL-bound state. Only minimal perturbations of
HDX rates were observed for the globules of the CP a and b subunits. These results provide experimental evidence to support
CARMIL-induced allosteric modulation of conformation of
the CP central b sheet and C-terminal tentacles. Moreover,
these results include perturbations similar to the effects seen
for CP binding to V-1, comparing V-1/CP complex with CP
(Figure 3).
We compared the effects of the two CARMIL fragments,
CBR115 and CBR71, to search for a role for the third region,
CAH3c, distal to the CPI and CSI motifs. At longer times
(>15 min) of incubation, no significant differences in perturbations were observed between the CP/CBR115 and CP/CBR71
complexes (Figures S6 and S7). However, at short time points
(10 s) HDX differences were observed in the CP a- and b-tentacles, comparing CBR115 with CBR71 (Figures S6 and S7). Residues 256–286 of the a-tentacle and 249–272 of the b-tentacle
displayed significantly more protection with CBR115 than with
CBR71. Both sets of residues are involved in binding to actin,
and the a-tentacle residues involve binding to V-1. The results
provide structural dynamic evidence in support of a regulatory
role for CARMIL residues 1035–1078, C-terminal to the CSI
motif, i.e., CAH3c.
Next, we examined and compared the differential deuterium
uptake of CARMIL CBR115 and CARMIL CBR71 peptides upon
CP binding (Figure 6). CBR115 and CBR71 peptides in isolation
were highly dynamic and underwent rapid HDX (>50%) even at
the shortest incubation time (10 s). CP-bound CARMIL CBR115
2800 Cell Reports 23, 2795–2804, May 29, 2018

and CBR71 showed overall protection (>10%) at incubation
times between 10 s and 15 min. Of note, the CARMIL peptide
1071–1078, which is present in CBR115 but absent in CBR71,
was significantly protected (>20%) upon CP binding (Figure 6),
providing additional support for a regulatory role for the C-terminal region beyond the CSI motif, i.e., CAH3c.
To compare further the interactions of CBR115 and CBR71
with CP, we measured the binding affinities with fluorescence
anisotropy (Figure 7). We measured the fluorescence anisotropy
of a fluorescent-labeled peptide, corresponding to a fragment of
CARMIL with the CPI motif, in complex with CP. Increasing concentrations of unlabeled CBR115 and CBR71 were added, to
compete with and release the fluorescent CPI-motif fragment,
decreasing the anisotropy. The results were fit well by a directcompetition model with 1:1 binding stoichiometry. The fitted
KD for CBR115 was 180 ± 120 pM, and the value for CBR71
was 470 ± 130 pM. This difference between CBR115 and
CBR71 is consistent with previous comparisons of the two
CARMIL fragments in assays of actin capping activity for CP
(Hernandez-Valladares et al., 2010; Takeda et al., 2010; Zwolak
et al., 2010b). We also performed this experiment using CP for
which the C-terminal tentacle region of the b subunit was truncated, ending at L243. The binding affinity was also tight, and
no significant differences were found comparing truncated CP
with full-length CP, consistent with previous results (Lukman
et al., 2012; Koike et al., 2016; Kim et al., 2012).
DISCUSSION
CARMIL and V-1 are two regulators that bind to and inhibit the
actin capping activity of CP via allosteric and steric mechanisms,
respectively. Structural models for CP/CARMIL and CP/V-1
complexes suggest that CARMIL proteins allosterically inhibit
the interaction of CP with actin by associating with sites on the

Figure 6. HDX-MS Analysis of CARMIL CBR71 and CARMIL CBR115, Comparing CP Complexes with Free CARMIL Fragments
(A) Two views of a cartoon representation of a co-crystal structure of CARMIL CBR115 peptide (ribbon) and CP (green surface), based on PDB 3LK3 (HernandezValladares et al., 2010). Unresolved CARMIL CBR115 residues 1005–1020 between CPI and CSI motifs and C-terminal residues 1034–1078 (CAH3c) are indicated as dashed lines. Differences in deuterium uptake induced by CP binding to CARMIL CBR115 are displayed as a color gradient (see scale at bottom) and
highlighted in the ribbon representation of CARMIL CBR115.
(B) Deuterium uptake curves for all CARMIL CBR71 peptides are shown for free (black) and CP-bound (green) states.
(C) Deuterium uptake curves for CARMIL CBR115 peptides are shown for free (black) and CP-bound (orange) states. Data shown are representative of two
independent experiments with error bars (SEM).

N-stalk, distal to the actin-binding site, whereas V-1 sterically
blocks association of CP with actin filament barbed ends by
binding to a major actin-binding site at the C-terminal region of
the a subunit. The binding sites for actin and V-1 on CP overlap,
so the allosteric effect of CARMIL leads to inhibition of binding
for both actin and V-1. The molecular basis of the allosteric
cross-talk and the nature of changes in structural dynamics
induced by binding of CARMIL and V-1 regulators have been
unclear.
To investigate this question, we utilized HDX-MS to provide
the first peptide resolution analysis of conformational dynamics
for CP alone and in complexes with CARMIL and V-1. We discovered that the CP N-stalk and the C-terminal a- and b-tentacles
regions are solvent-exposed and dynamic, relative to the buried
and protected central b sheet, consistent with predictions from
molecular dynamics simulations and biochemical studies.
Furthermore, we discovered that CARMIL binding results in
long-range conformational changes in CP, along the top of the
mushroom-like CP structure, which includes the V-1 and actin

binding sites, as predicted by biochemistry and molecular dynamics (Lukman et al., 2012; Koike et al., 2016; Kim et al.,
2012). In particular, our discoveries provide both an explanation
at the molecular level for previous observations that the allosteric
effect of CARMIL weakens the binding of CP for V-1 and a
foundation for a cellular model for actin polymerization in which
CPI-motif proteins work locally and enhance the activity of CP by
promoting the dissociation of the rapidly and freely diffusing inhibitor V-1 (Fujiwara et al., 2014).
In addition, we discovered a set of structural perturbations in
CP induced by V-1 binding that were similar to those induced
by CARMIL. V-1 binding affected HDX at its direct-binding site
on CP, and it allosterically influenced the CP N-stalk, which contains the CARMIL binding site. Together, perturbations resulting
from the binding of V-1 and CARMIL were found in a shared set
of CP residues comprising V-1 and CARMIL direct-binding sites,
as well as the CP inter-subunit interface. The results provide
evidence for long-distance communication between V-1 and
CARMIL binding sites.
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Figure 7. Binding of CARMIL CBR71 and CARMIL CBR115 to CP by
Fluorescence Anisotropy Titration
The fluorescence anisotropy of a CPI-motif-containing peptide with a fluorescent label, bound to CP, is plotted versus the total concentration of unlabeled CBR115 (black) or CBR71 (red). The points represent data values from
experiments in duplicate, and the lines are the best fits to a competition model
with 1:1 stoichiometry. The concentration of CP was 50 nM, and the concentration of the CPI-motif peptide was 20 nM. The fitted value for the binding
constant of the CPI-motif peptide to CP was 21.5 nM, which is within the
range of experimental values determined from independent direct-binding
experiments.

One striking and unexpected discovery ensuing from our results consists of effects on the C-terminal CP b-tentacle, which
is proposed to act as a flexible helix, extending away from the
body of CP in order to bind actin. The b-tentacle is critical for
CP function, in that C-terminal truncations and point mutations
decrease the binding affinity of CP for barbed ends (Narita
et al., 2006; Wear et al., 2003; Kim et al., 2010). We found that
the CP b-tentacle displayed rapid HDX, as expected for regions
that are solvent exposed and highly dynamic. Unexpectedly, we
found that the rate of HDX decreased when CP was bound to
either V-1 or CARMIL. Previously, an NMR study found that the
chemical shifts of the b-tentacle of CP were not affected by
V-1 binding (Zwolak et al., 2010a), and an X-ray crystal study
found that the base of the b-tentacle in the V-1/CP complex
had a structure similar to that of free CP (Takeda et al., 2010).
An NMR study also found only modest changes in three residues
(248–250) of the CP b subunit upon CARMIL binding (Zwolak
et al., 2010b).
Thus, our HDX results that V-1 and CARMIL binding significantly reduce the rate of deuterium incorporation at the distant
and mobile CP b-tentacle provide insight into the molecular
basis for how CP regulators affect capping of actin filaments.
Both V-1 binding and CARMIL binding modulate both of the
two actin binding sites of CP—the one found on the CP
b-tentacle and the one involving the a-tentacle, where V-1 binds.
Another discovery emerging from our study highlights the
roles of the different regions of the CP-binding domain of
CARMIL. CARMILs contain a CPI motif (residues 971–1004,
aka CAH3a) and a CSI motif (residues 1021–1035, aka
CAH3b), along with a C-terminal third region, known as CAH3c
(Zwolak et al., 2010b). Here, in a comparison of CARMIL fragment CBR115, which contains all three regions, with a shorter
2802 Cell Reports 23, 2795–2804, May 29, 2018

fragment, CBR71, which contains only the first two, we determined that CBR115 binds more tightly to CP than does
CBR71, in a fluorescence anisotropy binding assay; this result
is consistent with previous assays of the relative ability of
CBR115 and CBR71 to inhibit the actin capping activity of CP
(Zwolak et al., 2010b; Hernandez-Valladares et al., 2010). The
molecular determinants and structural basis of CARMIL
CBR115 binding to CP have not been established. Our study
provides structural evidence for interaction of this third region,
based on differences between how CBR115 and CBR71 interact
with CP. Moreover, we found that a CARMIL peptide corresponding to residues 1071–1078, which is present in CBR115
but absent in CBR71, was significantly protected upon CP binding, providing structural evidence for interaction of this C-terminal region.
In sum, these results indicate that the binding of either V-1 or
CARMIL to CP affects HDX at the known direct-binding sites
for both of the ligands—near the N-stalk and near the actinbinding CP a-tentacle. Unexpectedly, both ligands also affect
conformation near the actin-binding b-tentacle, which may
contribute further to their ability to inhibit actin binding. Both ligands affect a set of interior b sheet residues, suggesting a
mechanistic path for the allosteric connection between the
two direct-binding sites. The results also support a role for residues of CARMIL distal to the CPI and CSI motifs, in the CAH3c
region. Future studies will be required to define the physical basis for the allosteric coupling observed here and to delineate
the linkage between distinct sites on CARMIL that appear to
regulate cooperatively cytoskeletal dynamics through CP and
actin.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
His-tagged a1 and b2 subunits of mouse CP (pRSFDuet-1, pBJ 2041) were coexpressed in E. coli BL21 (DE3) pRIL. For CP lacking the b-tentacle, a premature stop codon was introduced, so that the C-terminal residue of the mouse
b2 subunit was L243 instead of C272 (pBJ 1891). The fusion proteins were
affinity purified on Ni Sepharose 6 Fast Flow (GE Healthcare). The CP eluates
were bound to ceramic hydroxyapatite type I, 40 mm (Bio-Rad) in 20 mM TrisHCl, 20 mM NaCl, 2 mM NaH2PO4, 125 mM CaCl2, 1 mM NaN3, 5 mM DTT
(pH 7.5) and eluted with a gradient to 200 mM NaH2PO4, 20 mM NaCl,
125 mM CaCl2, 1 mM NaN3, 5 mM DTT (pH 7.6). CPs were chromatographed
on Sephacryl S-200 HR (GE Healthcare) in 20 mM 3-(N-morpholino)propanesulfonic acid (MOPS), 100 mM KCl, 1 mM Tris(2-carboxyethyl)phosphine
(TCEP), 1 mM NaN3 (pH 7.2) and stored at 70 C.
Glutathione S-transferase (GST)-tagged CBR115 fragment of human
CARMIL1a (residues Glu964 to Ser1078, pGEX-6P-3, pBJ 2411) and GSTtagged CBR71 fragment of human CARMIL1a (residues Glu964 to Val1034,
pGEX-6P-3, pBJ 2052) were each expressed in E. coli BL21 Star (DE3). The
fusion proteins were affinity purified on Glutathione Sepharose 4 Fast Flow
(GE Healthcare), followed by cleavage with PreScission Protease (GE Healthcare). The cleaved CBR peptides were bound to POROS GoPure XS (Applied
Biosystems) in 20 mM NaH2PO4, 100 mM EDTA, 1 mM NaN3, 5 mM DTT
(pH 7.5) and eluted with a gradient to 1 M NaCl in the same buffer. Trace
GST was removed by re-incubating with Glutathione Sepharose 4 Fast Flow.
Purified CBR peptides were dialyzed into 20 mM MOPS, 100 mM KCl, 1 mM
TCEP, 1 mM NaN3, 0.005% Tween 20 (pH 7.2) and stored at 70 C.
GST-tagged human V-1 (pGEX-KG, pBJ 2438) was expressed in E. coli
BL21 Star (DE3). The fusion protein was affinity purified on Glutathione
Sepharose 4 Fast Flow, followed by cleavage with bovine thrombin (MP Biomedicals). V-1 was chromatographed on Sephacryl S-200 HR in 20 mM

MOPS, 100 mM KCl, 1 mM TCEP, 1 mM NaN3, 0.005% Tween 20 (pH 7.2).
Trace GST was removed by re-incubating with Glutathione Sepharose 4
Fast Flow. Purified V-1 was stored at 70 C.
Hydrogen Deuterium Exchange Mass Spectrometry
CP, CP/CARMIL CBR115, CP/CARMIL CBR71, and CP/V-1 samples were
buffer exchanged with 1 3 PBS (pH 7.4). HDX was initiated by diluting samples (25 mM, 2 mL) 10-fold with 1 3 PBS prepared in D2O, or 1 3 PBS H2O
buffer for samples measured for no-deuterium control. At different time intervals (10, 30, 60, 120, 360, 900, 3,600, and 14,400 s), the labeling reaction
was quenched by rapidly decreasing the pH to 2.5 with 30 mL of
quench buffer (3 M urea, 1% trifluoroacetic acid, H2O) at 4 C. The protein
mixture was immediately injected into a custom-built HDX sample-handling
device that enabled in-column digestion with resin-immobilized pepsin
(2 3 20 mm) at a flow rate of 100 mL/min in 0.1% formic acid. The resulting
peptic peptides were captured on a ZORBAX Eclipse XDB C8 column (2.1 3
15 mm, Agilent) for desalting (3 min). The C8 column was then switched inline
with a Hypersil Gold C18 column (2.1 m 3 50 mm, Thermo Fisher Scientific),
and a linear gradient (4%–40% acetonitrile, 0.1% formic acid, 50 mL/min flow
rate, over 5 min) was used to separate the peptides and direct them to a
LTQ-FTICR mass spectrometer (Thermo Fisher Scientific) equipped with an
electrospray ionization source. Valves, columns, and tubing for protein
digestion and peptide separation were immersed in an ice-water bath to
minimize back-exchange.
To map the peptic peptides, the digest, in the absence of HDX, was submitted to accurate mass analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS) with the LTQ-FTICR, and the peptic peptides were
identified using Mascot (Matrix Science). Raw HDX spectra and peptide sets
also were submitted to HDX Workbench (Pascal et al., 2012) for calculation
and data visualization in a fully automated fashion. Peptides for each run
were assessed based on relative representation and statistical validation.
Only the top six peptides from each MS scan were used in the final analysis.
The extent of HDX at each time point was calculated by subtracting the
centroid of the isotopic distribution of the non-deuterated peptide from that
of the deuterated peptide. The relative deuterium uptake was plotted versus
the labeling time to yield kinetic curves. For comparison between apo states
and the complexes, differences in HDX for all incubation time points were
calculated. Absolute differences in perturbation values larger than 5% D
were considered significant. The 15-min time point was mapped onto the protein three-dimensional (3D) structure for data visualization. Peptide digestions
were optimized under HDX assay conditions, and the mass calculations
included accommodation for back exchange with solvent.
Fluorescence Anisotropy Binding Titrations
CBR stock solutions were dialyzed into PBS (pH 7.4) with 0.005% Tween 20,
and protein concentrations were determined by absorbance at 205 nm (Anthis and Clore, 2013) (CBR115 ε205nm = 409,870 M–1 cm–1, CBR71 ε205nm =
245,320 M–1 cm–1). A fluorescent CARMIL1 peptide comprising only the
CPI motif (G969-A1005, N-carboxytetramethylrhodamine [TAMRA], C-amide)
was purchased from WatsonBio Sciences; labeled CPI concentration was
determined by absorbance at 554 nm (TAMRA ε554nm = 80,000 M–1 cm–1).
CP concentration was determined by absorbance at 280 nm (CP ε280nm =
78,935 M–1 cm–1).
Fluorescence anisotropy experiments were performed on a one-channel
L-format QM-2000 spectrofluorometer using FelixGX software (Photon Technology International). Polarized excitation was at 552 nm; polarized emission
was measured at 582 nm. Experiments were performed at 25 C in 20 mM
MOPS, 100 mM KCl, 1 mM TCEP, 1 mM NaN3, 0.005% Tween 20 (pH 7.2).
CBRs were titrated into a solution containing 20-nM-labeled CPI and 50 nM
CP, with a 2-min incubation after each addition. For each anisotropy experimental value, 1 measurement was recorded every 5 s and averaged over 120 s.
The data were analyzed using a competitive binding model, assuming that
both the CPI and the CBRs compete for the same binding site on CP. The
competition model assumes that labeled, X* (CPI), and unlabeled, X (CBR),
peptides bind to the same site on CP, defined by two equilibrium dissociation
constants, KD* = [X*][CP]/[X*CP] and KD = [X][CP]/[XCP], where [X*], [X] and
[CP] are free concentrations of the species.

The observed anisotropy is defined as in Equation (1a)
A = Ao + ðAmax Ao Þn

(Equation 1a)

where Ao is the anisotropy of free labeled peptide X*, Amax is the anisotropy of
the X*CP complex and v* is the fraction of labeled peptide bound to CP:


v = ½X CP ½X tot = ½X ½CP KD ½X tot :
(Equation 1b)
In Equation (1b), the free concentrations of [X*] and [CP] can be found
numerically by solving the system of mass conservation Equations (2) using
Scientist software (MicroMath Scientific Software):

½X tot = ½X  + ½X CP = ½X  + ½X ½CP KD
(Equation 2a)
½Xtot = ½X + ½XCP = ½X + ½X½CP=KD

(Equation 2b)


½CPtot = ½CP + ½XCP + ½X CP = ½CP + ½X½CP=KD + ½X ½CP KD
(Equation 2c)
Using Equations (1) and (2) we fit the experimentally observed anisotropy
change (A) as a function of three independent variables [X*]tot, [X]tot, and [CP]tot
to determine the values of four parameters: Ao, Amax, KD, and KD*.
Information on all reagents and software used in this study are listed in
Table S1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and one table and can be
found with this article online at https://doi.org/10.1016/j.celrep.2018.04.096.
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Supplemental Figures

Figure S1. HDX-MS of free CP identifies dynamic α-tentacle, β-tentacle, and N-stalk, with relative protection of
central β-sheet. Related to Figure 2. The percentage of deuterium incorporation for selected peptides is mapped onto the
cartoon representation of CP structure (PDB 3AAE (Takeda et al., 2010)) for (A) 10 sec and (B) 4 hr incubation times.
Peptide color corresponds to level of relative deuterium uptake (see scale).
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Figure S2. HDX-MS analysis of CP α-subunit, comparing V-1 / CP complex with free CP. Related to Figure 3.
Deuterium uptake curves for all CP α-subunit peptides are shown for unbound CP (black) and V-1-bound CP (pink) states.
Data shown are representative of two independent experiments with error bars (standard error of the mean [SEM]).

Page 2

Figure S3. HDX-MS analysis of CP β-subunit, comparing V-1 / CP complex with free CP. Related to Figure 3.
Deuterium uptake curves for all CP peptides are shown for unbound CP (black), and V-1-bound CP (pink) states. Data
shown are representative of two independent experiments with error bars (standard error of the mean [SEM]).
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Figure S4. Comparison of two CP structures. Related to Figure 2. Two orthogonal views comparing two structures
from PDB 3AAE (Takeda et al., 2010). The CP β-subunit molecules B (green) and D (pink) display two alternative CP βtentacle conformations. The CP α-subunit molecules A and C (grey surface representation) are superimposed, with RMSD
= 0.033.

Figure S5. HDX-MS analysis of V-1, comparing V-1 / CP complex with free V-1. Related to Figure 4. Deuterium
uptake curves for all V-1 peptides are shown for unbound V-1 (black), and CP-bound V-1 (purple) states. Data shown are
representative of two independent experiments with error bars (standard error of the mean [SEM]).
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Figure S6. HDX-MS analysis of CP α-subunit, comparing CARMIL CBR71 / CP complex and CARMIL CBR115 /
CP complex with free CP. Related to Figure 5. Deuterium uptake curves for all CP α-subunit peptides are shown for free
CP (black), CBR71-bound CP (red), and CBR115-bound CP (blue) states. Data shown are representative of two
independent experiments with error bars (standard error of the mean [SEM]).
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Figure S7. HDX-MS analysis of CP β-subunit, comparing CARMIL CBR71 / CP complex and CARMIL CBR115 /
CP complex with free CP. Related to Figure 5. Deuterium uptake curves for all CP β-subunit peptides are shown for free
CP (black), CBR71-bound CP (red), and CBR115-bound CP (blue) states. Data shown are representative of two
independent experiments with error bars (standard error of the mean [SEM]).
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Supplemental Table S1. Table of Reagents and Resources used in our study. Related to Figure 2.
REAGENT or RESOURCE

SOURCE

IDENTIFIER

Novagen

69450

Cells
BL21(DE3)
Deposited Data
Will be deposited at
Raw and analyzed data mass spectrometry data

This paper

https://www.mendeley.
com/.

Plasmids
His-tagged-α1 and β2 subunits of mouse CP (pRSFDuet-1)

Cooper lab

pBJ 2041

Cooper lab

pBJ 1891

Cooper lab

pBJ 2411

Cooper lab

pBJ 2052

Cooper lab

pBJ 2438

Graphpad

N/A

His-tagged-α1 anδ β2 subunits of mouse CP (pRSFDuet-1)
with premature stop codon after Leu 243 of β2.
GST-tagged CBR115 fragment of human CARMIL1a
(Glu964 - Ser1078) in pGEX-6P-3.
GST-tagged CBR71 fragment of human CARMIL1a (Glu964
- Val1034) in pGEX-6P-3.
GST-tagged human V-1 (pGEX-KG
Software and Equipment
Statistics: Prism 7

Photon Technology
Spectrofluorometer: One-channel L-format QM-2000

N/A
International
Photon Technology

FelixGL software for fluorometer

N/A
International
MicroMath Scientific

Binding titration analysis - Scientist software

N/A
Software

LTQ-FTICR mass spectrometer

Thermo Fisher

13437

Mass analysis/LC-MS/MS: Mascot

Matrix Science

N/A

HDX Analysis

HDX Workbench
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